These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2128756)
21. Involvement of cholinergic and GABAergic systems in the reversal of memory disruption by NS-105, a cognition enhancer. Ogasawara T; Itoh Y; Tamura M; Mushiroi T; Ukai Y; Kise M; Kimura K Pharmacol Biochem Behav; 1999 Sep; 64(1):41-52. PubMed ID: 10494996 [TBL] [Abstract][Full Text] [Related]
22. Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical cholinergic markers. Mandel RJ; Chen AD; Connor DJ; Thal LJ J Pharmacol Exp Ther; 1989 Nov; 251(2):612-9. PubMed ID: 2810114 [TBL] [Abstract][Full Text] [Related]
23. Selective memory loss following nucleus basalis lesions: long term behavioral recovery despite persistent cholinergic deficiencies. Bartus RT; Flicker C; Dean RL; Pontecorvo M; Figueiredo JC; Fisher SK Pharmacol Biochem Behav; 1985 Jul; 23(1):125-35. PubMed ID: 4041042 [TBL] [Abstract][Full Text] [Related]
24. Transient impairment of recognition memory following ibotenic-acid lesions of the basal forebrain in macaques. Aigner TG; Mitchell SJ; Aggleton JP; DeLong MR; Struble RG; Price DL; Wenk GL; Pettigrew KD; Mishkin M Exp Brain Res; 1991; 86(1):18-26. PubMed ID: 1756788 [TBL] [Abstract][Full Text] [Related]
25. Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat. Flicker C; Dean RL; Watkins DL; Fisher SK; Bartus RT Pharmacol Biochem Behav; 1983 Jun; 18(6):973-81. PubMed ID: 6889421 [TBL] [Abstract][Full Text] [Related]
26. Effects of NBm lesions on T-maze performance and thalamic biochemistry. Connor DJ; Langdon DJ; Langlais PJ; Thal LJ Neurobiol Aging; 1993; 14(6):535-7. PubMed ID: 7905188 [TBL] [Abstract][Full Text] [Related]
27. Memory disturbances following ibotenic acid injections in the nucleus basalis magnocellularis of the rat. Mayo W; Kharouby M; Le Moal M; Simon H Brain Res; 1988 Jul; 455(2):213-22. PubMed ID: 3401780 [TBL] [Abstract][Full Text] [Related]
28. Lesions in nucleus basalis magnocellularis and medial septal area of rats produce qualitatively similar memory impairments. Hepler DJ; Olton DS; Wenk GL; Coyle JT J Neurosci; 1985 Apr; 5(4):866-73. PubMed ID: 4038997 [TBL] [Abstract][Full Text] [Related]
29. Selective cholinergic lesions in the rat nucleus basalis magnocellularis with limited damage in the medial septum specifically alter attention performance in the five-choice serial reaction time task. Harati H; Barbelivien A; Cosquer B; Majchrzak M; Cassel JC Neuroscience; 2008 Apr; 153(1):72-83. PubMed ID: 18339485 [TBL] [Abstract][Full Text] [Related]
30. Differential effects of 192IgG-saporin and NMDA-induced lesions into the basal forebrain on cholinergic activity and taste aversion memory formation. Gutiérrez H; Gutiérrez R; Silva-Gandarias R; Estrada J; Miranda MI; Bermúdez-Rattoni F Brain Res; 1999 Jul; 834(1-2):136-41. PubMed ID: 10407102 [TBL] [Abstract][Full Text] [Related]
31. Effect of 6-hydroxydopamine-induced lesions of the dorsal noradrenergic bundle on steady-state operant behaviour. Morley MJ; Bradshaw CM; Szabadi E Psychopharmacology (Berl); 1987; 93(4):520-5. PubMed ID: 3124186 [TBL] [Abstract][Full Text] [Related]
32. Neurotoxic lesions of the nucleus basalis induced by colchicine: effects on spatial navigation in the water maze. Mundy WR; Barone S; Tilson HA Brain Res; 1990 Apr; 512(2):221-8. PubMed ID: 2354359 [TBL] [Abstract][Full Text] [Related]
33. Differential alterations of cortical cholinergic and neurotensin markers following ibotenic acid lesions of the nucleus basalis magnocellularis. Lapchak PA; Araujo DM; Pasinetti G; Hefti F Brain Res; 1993 Jun; 613(2):239-46. PubMed ID: 8186970 [TBL] [Abstract][Full Text] [Related]
34. Basal forebrain lesions in monkeys disrupt attention but not learning and memory. Voytko ML; Olton DS; Richardson RT; Gorman LK; Tobin JR; Price DL J Neurosci; 1994 Jan; 14(1):167-86. PubMed ID: 8283232 [TBL] [Abstract][Full Text] [Related]
35. Lesions of the nucleus basalis magnocellularis in immature rats: short- and long-term biochemical and behavioral changes. Zupan G; Casamenti F; Scali C; Pepeu G Pharmacol Biochem Behav; 1993 May; 45(1):19-25. PubMed ID: 7685915 [TBL] [Abstract][Full Text] [Related]
36. Effects of scopolamine and unilateral lesions of the basal forebrain on T-maze spatial discrimination and alternation in rats. Beninger RJ; Jhamandas K; Boegman RJ; el-Defrawy SR Pharmacol Biochem Behav; 1986 May; 24(5):1353-60. PubMed ID: 3725838 [TBL] [Abstract][Full Text] [Related]
37. Long-term effects of selective immunolesions of cholinergic neurons of the nucleus basalis magnocellularis on the ascending cholinergic pathways in the rat: a model for Alzheimer's disease. Szigeti C; Bencsik N; Simonka AJ; Legradi A; Kasa P; Gulya K Brain Res Bull; 2013 May; 94():9-16. PubMed ID: 23357177 [TBL] [Abstract][Full Text] [Related]
38. Phospholipid and phospholipid metabolites in rat frontal cortex are decreased following nucleus basalis lesions. Holmes TC; Nitsch RM; Erfurth A; Wurtman RJ Ann N Y Acad Sci; 1993 Sep; 695():241-3. PubMed ID: 8239290 [TBL] [Abstract][Full Text] [Related]
39. Electroencephalographic effects induced by choline pivaloyl esters in scopolamine-treated or nucleus basalis magnocellularis lesioned rats. Rispoli V; Rotiroti D; Carelli V; Liberatore F; Scipione L; Marra R; Tortorella S; Di Rienzo B Pharmacol Biochem Behav; 2004 Aug; 78(4):667-73. PubMed ID: 15301920 [TBL] [Abstract][Full Text] [Related]
40. Forebrain norepinephrine: role in controlled information processing in the rat. Cole BJ; Robbins TW Neuropsychopharmacology; 1992 Sep; 7(2):129-42. PubMed ID: 1418302 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]